@FiercePharma: Sanofi could kill two birds with one stone with buyout of India's Universal Medicare. 1. Emerging markets. 2. OTC brands. Story | Follow @FiercePharma
> It's official: Forest Laboratories ($FRX) shareholders chose the company's board nominees over the slate proposed by activist investor Carl Icahn, ending the proxy fight in a loss for the challengers. Release
> PharMerica ($PMC) isn't impressed by Omnicare's ($OCR) $15-per-share buyout bid; analysts figure private equity may swoop in with a higher offer. Report
> Afexa Life Sciences reaffirmed its rejection of a hostile takeover bid from Paladin Labs. Article
> Researchers didn't find a major heart risk with new psoriasis drugs, but say more study is needed to make sure. Piece
> Zacks put Onyx Pharmaceuticals on its "strong sell" list after Q2 losses came in wider than the average forecast. News
> Growing business from Chinese clients pushed ShangPharma's sales up, helping the research services firm diversify away from multinationals. Report
Biotech News
@FierceBiotech: Bayer, Algeta shares spike as FDA fast-tracks blockbuster hopeful Alpharadin for prostate cancer. Item | Follow @FierceBiotech
@JohnCFierce: NIH conflict rules for researchers. Researchers have to notify at $5K, but people have to ask to see it. No public site. That's a mistake. | Follow @JohnCFierce
@RyanMFierce: Samsung entering the genomic analysis fray with cloud-based service, free pilot phase from Sept. to Nov. News | Follow @RyanMFierce
@MaureenFierce: "Unabomber Copycat" Group Threatens Nanotechnology Researchers. Piece | Follow @MaureenFierce
> Peregrine shares spike on Ph2 cancer data. Report
> Boehringer Ingelheim gets the dirt flying on $42.5M R&D facility. More
> SurModics slashes delivery tech workforce, closes plant in restructuring. Story
> Docs wary of any biosimilars that lack compelling data. Article
> NIH 's final conflict rules for researchers spur new controversy. Details
> United vows to file NDA on PAH drug after it flunks Ph3. News
Drug Delivery News
> Unilife boasts 'world's first' safety mechanism in multi-chamber syringe. More
> Alkermes stock upgrade validates drug delivery focus. News
> New nasal delivery method may offer faster, better pain relief. Report
> Drug-delivery company SurModics cuts 9% of workforce after J&J loss. Story
> Echo Therapeutics video shows pain-free skin prep. Details
> Microwaves get bacteria to open sesame. Article
Medical Device News
> Occlutech reports closing of $21.6M financing. More
> Thermo Fisher wraps up Phadia buy. Report
> Aethlon, Sarcoma Oncology Center to study hemopurifier in cancer patients. Article
> GE lays off 81 in Milwaukee. Story
> SurModics cutting 9% of workforce in realignment. News
> Medtronic sees net earnings slide 1% in Q1. Details
And Finally... New narcolepsy cases tripled in China after the swine flu pandemic, but not because of vaccines, study finds. Report